Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

August 18, 2022 • 01:02:07
Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update
MitoAction Expert Series
Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

Aug 18 2022 | 01:02:07

/

Show Notes

There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from the REN001 Phase1b LC-FAOD Study.

Other Episodes

Episode

May 18, 2022 • 00:56:47
Episode Cover

Psychiatric Disorders in Mitochondrial Disease

Dr. Andrew Nierenberg from Massachusetts General Hospital to learn more about Psychiatric Disorders in Mitochondrial Diseases and Mitochondrial Dysregulation in Psychiatric Disorders. Andrew Nierenberg...

Listen

Episode

April 12, 2022 • 00:46:05
Episode Cover

Pain - 7/11/08 - Dr. Irina Anselm

MitoAction welcomed Dr. Irina Anselm, pediatric neurologist and head of the mitochondrial disease clinic at Children’s Hospital Boston to discuss the topic of pain...

Listen

Episode

November 21, 2025 • 01:05:22
Episode Cover

Managing challenges and maximizing success in chronic mechanical ventilation

Mechanical ventilation can be a critical component of a comprehensive and successful plan to support a patient’s respiratory needs in helping them maximize their...

Listen